Food Colours Linked to Adverse Behaviour, Lowered – EFSA Ruling
The European Food Safety Authority (EFSA) issued recommendations that the acceptable daily intakes (ADI) for three of the questionable food additives should be lowered — but rather strangely, not because of their effect on childrens’ behaviour.
The controversial additives — Quinoline Yellow (E104), Sunset Yellow FCF (E110), Ponceau 4R (E124), Tartrazine (E102), Azorubine/Carmoisine (E122) and Allura Red AC (E129) — were given controversial status in 2007 when a study commissioned by the UK’s Food Standard’s Authority, and undertaken by the University of Southampton, concluded they caused behavioural problems in children. The European Commission subsequently asked EFSA to consider whether the additives should be banned, but after examining the study, its scientists said there were no grounds for taking such action.
Now EFSA has issued opinions on the six additives as part of an ongoing systematic review of the safety of all approved additives. In three cases — for Quinoline Yellow, Sunset Yellow FCF and Ponceau 4R — EFSA said the maximum recommended amount consumed by adults and children should be cut. But the reasons for this advice have nothing to do with the ability of these additives to produce tantrums in children.
- For Quinoline Yellow, the ADI has been lowered from 0-10mg per kg of bodyweight (BW) a day to 0.5 mg/kg bw/day following analysis of a rat study on the long-term effects on reproduction and development of pups.
- For Ponceau 4R, the ADI has been reduced from 0-4 mg/kg body weight (bw)/day to 0.7 mg/kg bw/day, based on a 1974 study in mice that linked the ingredients with kidney disease.
- And for Sunset Yellow, the ADI has been reduced from 0-2.25 mg/kg bw/day to 1.0 mg/kg bw/day, based on evidence for effect on the testes of rats.
John Larsen, chair of EFSA’s scientific panel on additives, said: We have now reduced the ADIs for three of the six colours we assessed, but for different reasons in each case as different data were available on each individual compound. The data which are currently available — including the Southampton study itself — did not substantiate a causal link between the individual colours and possible behavioural effects.
Despite EFSA’s insistence that there is no clear evidence the colourants cause behavioural problems in youngsters, the European Commission has still ruled that from 10 July next year any company using them will need to print a warning on the label that reads: “May have an adverse effect on activity and attention in children.” This is likely to put most manufacturers off using the ingredients, amounting to a ban by default.
Sunday 17th January 2016
Kick start the New Year with our detoxification cookery day. Discover the key foods and nutrients to incorporate in your diet to enhance your detoxification pathways, how to remove toxins safely, signs and symptoms of toxic overload, consequences and links to long term chronic health conditions and the importance of supporting gut barrier health. This day will include practical recipes and meal planning solutions to help you plan a cleansing programme with clients together with details of the most effective supplements and nutrients to incorporate.Click for further information
Sunday 13th March 2016
In Functional Nutrition we often utilise the 5 R programme to support digestive health, restore and repair the gut barrier and tackle ongoing digestive imbalances. This practical cookery day will provide you with the resources you need to put this into action – discover the top foods to include and those to avoid, the importance of fermented foods and how to incorporate them in the diet. You will see a range of delicious recipes demonstrated to support gut healing and for lowering inflammation in the digestive tract and we will discuss different dietary approaches that may be beneficial for resolving ongoing gut symptomsClick for further information
- This evening seminar will take the gathering un...
- Psychiatric disorders in general, and major dep...
N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic ReviewFor people with obsessive compulsive disorders ...
- Dr Carrie Decker ND discusses the role of the p...
- In a clinical trial undertaken by Hudson and Ki...
Updates on your email
Don't miss out on our email updates